Navigation Links
AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
Date:3/5/2008

BENICIA, Calif., March 5 /PRNewswire/ -- AcroMetrix, a global leader in quality control materials and standards for molecular and serological diagnostics, announced today that it has entered into an agreement with Beckman Coulter Inc. for the development and supply of molecular quality control standards for various molecular targets.

AcroMetrix provides In Vitro Diagnostic manufacturers and clinical laboratories with quality control products for molecular testing of infectious disease, oncology, and genetics. These products provide a means by which to establish and monitor assay performance and estimate accuracy and detect systematic errors in molecular diagnostic assays.

"This agreement demonstrates the importance of quality control and standardization in molecular diagnostic testing. We are excited to be working with Beckman Coulter, a leader in the In Vitro Diagnostic industry," said Michael J. Eck, President and CEO for AcroMetrix.

The agreement includes the initial development and supply of quality control standards for 10 molecular targets that will be used in the development of Beckman Coulter's molecular UniCel DxN instrument. This agreement was made possible through AcroMetrix' Contract Manufacturing department which provides customers with high quality, tailored solutions enabling customers to benefit on the years of experience developed by AcroMetrix in the field of molecular quality control materials.

About AcroMetrix - AcroMetrix, with facilities in Benicia, California and Alkmaar, the Netherlands, provides a comprehensive line of molecular and serological diagnostic quality control products that assist laboratories in meeting current regulations regarding quality. AcroMetrix maintains this leadership role by consistently developing innovative standards, external run controls, and validation kits for molecular and serological testing in clinical diagnostics and blood screening laboratories. For more information on AcroMetrix please visit the company web site at http://www.acrometrix.com.


'/>"/>
SOURCE AcroMetrix
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Touch Bionics signs U.S. distribution agreement with SPS
2. Martek Signs Multi-Year Sole-Source Supply Agreement with Numico
3. The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions
4. Enigma Signs Real-Time PCR Licences With Applera
5. Foamix Signs Term Sheet to Acquire License to Organo-Boron Antifungal Molecules - Will Target the $11 Billion Dollars Fungal Infection Market
6. SemBioSys signs option agreement for safflower-produced food ingredient
7. AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000
8. Protalix BioTherapeutics Signs Lease Agreement for Expansion of its Manufacturing and Research Facility in Carmiel, Israel
9. University of Maryland, Baltimore BioPark Signs Gliknik Inc. as First Tenant in Its BioInnovation Center in Building Two
10. Amic Signs Non-Exclusive License Agreement With Roche Diagnostics for Key Cardiac Marker NT-proBNP
11. Kiwa Signs Letter of Intent with Huaxing Animal Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
Breaking Biology Technology:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
Breaking Biology News(10 mins):